Johnson & Johnson / Bavarian Nordic / CSR Non / CSR / Janssen / Bristol-Myers Squibb / /
Country
Germany / United States / Canada / Denmark / /
Event
Business Partnership / FDA Phase / Environmental Issue / /
Facility
Kvistgaard facility / Berlin facility / /
IndustryTerm
manufacturing facility / energy saving solutions / manufacturing activities / energy saving measures / energy consumption helps defining reduction / treatment of prostate cancer / treatment of life-threatening diseases / increased manufacturing activities / overall energy consumption / energy monitoring system / manufacturing efficiency / improved manufacturing efficiency / water cooling systems / product manufacturing / proactive solutions / manufacturing process / energy / quality management / energy consumption / Energy screening / manufacturing / annual relative energy consumption / pharmaceutical industry works / chemicals / energy screenings / /
MedicalCondition
smallpox / strain / metastatic castration-resistant prostate cancer / prostate cancer / cancers / advanced prostate cancer / cancer / disease / Ebola / Sickness / traditional smallpox / diseases / infectious diseases / Active cancer / /
MedicalTreatment
immunotherapies / vaccination / immunotherapy / /
Organization
U.S. Government / United Nations / Confederation of Danish Industry / European Union / /
Position
Paul Chaplin President & CEO / CEO / Statements Independent Auditor / health and safety specialist / /
Bavarian Nordic - CSR Report 2014